Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | ANPEP | P15144 | 1/20 | 0.52 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.52 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.52 |
| ▸ | CTSK | P43235 | 4/20 | 0.51 |
| ▸ | CTSB | P07858 | 2/20 | 0.50 |
| ▸ | CTSS | P25774 | 2/20 | 0.48 |
| ▸ | CTSL | P07711 | 1/20 | 0.48 |
| ▸ | IDO1 | P14902 | 1/20 | 0.48 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.48 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL728728 | 1.00 | ALDH1A1 (0.53) | ALDH1A1ANPEPRNPEPDNPEPCTSK | |
| SCHEMBL353695 | 1.00 | ALDH1A1 (0.53) | ALDH1A1ANPEPRNPEPDNPEPCTSK | |
| Hydrochloric Acid SCHEMBL7365467 | 0.98 | ALDH1A1 (0.51) | ALDH1A1ANPEPRNPEPDNPEPCTSK | |
| Hydrochloric Acid SCHEMBL1810902 | 0.98 | ALDH1A1 (0.51) | ALDH1A1ANPEPRNPEPDNPEPCTSK | |
| Hydrochloric Acid SCHEMBL9697973 | 0.98 | ALDH1A1 (0.51) | ALDH1A1ANPEPRNPEPDNPEPCTSK | |
| Oxalic Acid SCHEMBL4393417 | 0.95 | ANPEP (0.49) | ALDH1A1ANPEPRNPEPDNPEPCTSK | |
| Oxalic Acid SCHEMBL4393420 | 0.95 | ANPEP (0.49) | ALDH1A1ANPEPRNPEPDNPEPCTSK | |
| Toluene SCHEMBL27746059 | 0.94 | ANPEP (0.48) | ALDH1A1ANPEPRNPEPDNPEPCTSK | |
| Alcohol SCHEMBL28297582 | 0.94 | ANPEP (0.48) | ALDH1A1ANPEPRNPEPDNPEPCTSK | |
| Phenylalanine SCHEMBL11683484 | 0.91 | SLC7A5 (0.61) | ALDH1A1ANPEPRNPEPDNPEPCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 387 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120192379-A | Marine cyclic peptide and synthesis method and application thereof | 内蒙古大学 | 2025-06-24 | — | — | CN | claimed |
| CN-119161409-A | ((S) -2-amino-3- (4- (benzyloxy) phenyl) propionyl) -L-leucine benzyl ester hydrochloride, and preparation method and application thereof | 成都普康唯新生物科技有限公司 | 2024-12-20 | — | — | CN | claimed |
| EP-3275864-B1 | COMPOUND OF 3-HYDROXYL PYRIDINE, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE THEREOF | SHENYANG SUNSHINE PHARMACEUTICAL CO LTD (CN) | 2019-08-14 | — | — | EP | claimed |
| US-10149841-B2 | Compound of 3-hydroxyl pyridine, preparation method thereof and pharmaceutical use thereof | SHENYANG SUNSHINE PHARMACEUTICAL CO. LTD. (CN) | 2018-12-11 | — | — | US | claimed |
| US-20180117021-A1 | COMPOUND OF 3-HYDROXYL PYRIDINE, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE THEREOF | SHENYANG SUNSHINE PHARMACEUTICAL CO., LTD. (CN) | 2018-05-03 | — | — | US | claimed |
| EP-3275864-A1 | COMPOUND OF 3-HYDROXYL PYRIDINE, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE THEREOF | Shenyang Sunshine Pharmaceutical Co., Ltd. (CN) | 2018-01-31 | — | — | EP | claimed |
| CN-102320950-B | Method for synthesizing acetic acid through carbonylation | SHANGHAI HUAYI GROUP CO | 2015-05-13 | — | — | CN | claimed |
| CN-103333089-A | Crystal form of N-[(2S, 3R)-4-phenyl-3-benzyl-3-formylaminobenzoxy-2-hydroxybutyryl]-L-benzyl leucine and preparation method thereof | SHENZHEN MAIN LUCK PHARMACEUTICALS INC | 2013-10-02 | — | — | CN | claimed |
| CN-102241693-B | N,N'-di-(1-methyl-beta-carboline-3-formyl)-lysly aminoacid benzyl esters, synthetic method thereof and application thereof | UNIV CAPITAL MEDICAL SCIENCES | 2013-08-28 | — | — | CN | claimed |
| CN-102250202-B | 1-paranitrophenyl-beta-carboline-3-formyl amine acid carbamates and synthesis method and use thereof | UNIV CAPITAL MEDICAL SCIENCES | 2013-08-28 | — | — | CN | claimed |
| CN-101497615-B | Substituted purine, preparation and use in medicine | ZHEJIANG MED XINCHANG PHARM | 2010-12-15 | — | — | CN | claimed |
| CN-101906102-A | Beta-carboline alkaloid derivative, preparation method and application thereof | UNIV CAPITAL MEDICAL | 2010-12-08 | — | — | CN | claimed |
| CN-101891647-A | Preparation method for ubenimex | APELOA KANGYU PHARMACEUTICAL CO LTD | 2010-11-24 | — | — | CN | claimed |
| CN-101658800-A | Catalyst system for use in preparation of acetic acid and acetic anhydride or synchronous preparation of acetic acid and acetic anhydride and preparation method thereof | SHANGHAI COKING & CHEMICAL COR | 2010-03-03 | — | — | CN | claimed |
| CN-101659607-A | Method for preparing acetic acid and acetic anhydride respectively or synchronously | SHANGHAI COKING & CHEMICAL COR | 2010-03-03 | — | — | CN | claimed |
| CN-100572382-C | The chemical sproof heterogeneous ring compound of reversing tumor cell, its preparation method and application | UNIV CAPITAL MEDICAL (CN) | 2009-12-23 | — | — | CN | claimed |
| CN-101597289-A | 2-tryptophyl-beta-tetrahydro carboline-3-formyol amino-acid benzyl ester and its production and application | UNIV CAPITAL MEDICAL (CN) | 2009-12-09 | — | — | CN | claimed |
| CN-101597290-A | β-Ka Lin-3-formyl tryptophyl amino-acid benzyl ester and its production and application | UNIV CAPITAL MEDICAL (CN) | 2009-12-09 | — | — | CN | claimed |
| CN-101497615-A | Substituted purine, preparation and use in medicine | XINCHANG PHARMACEUTICAL FACTORY ZHEJIANG MEDICINE CO LTD (CN) | 2009-08-05 | — | — | CN | claimed |
| CN-101239979-A | Heterocyclic compound capable of inversing tumor cell drug tolerance, preparation method and application thereof | UNIV CAPITAL MEDICAL SCIENCES (CN) | 2008-08-13 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180117021-A1 | COMPOUND OF 3-HYDROXYL PYRIDINE, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE THEREOF | EGLN3, EGLN2, P4HA1 | ALDH1A1 243/4885ANPEP 2473/4885RNPEP 1790/4885 |
| US-10149841-B2 | Compound of 3-hydroxyl pyridine, preparation method thereof and pharmaceutical use thereof | EGLN3, EGLN2, P4HA1 | ALDH1A1 243/4885ANPEP 2473/4885RNPEP 1790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.